Home practice and quality of life among patients with neurofibromatosis randomized to a mind-body intervention
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 42, 114-118
Abstract
No abstract availableKeywords
Funding Information
- Children’s Tumor Foundation
- National Center for Complementary and Integrative HealthNational Center for Complementary and Integrative Health (NCCIH)
- National Institute on Drug AbuseNational Institute on Drug Abuse (NIDA)
This publication has 18 references indexed in Scilit:
- The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot studyJournal of Neuro-Oncology, 2014
- Schwannomas and Their PathogenesisBrain Pathology, 2014
- Advances in the treatment of neurofibromatosis-associated tumoursNature Reviews Clinical Oncology, 2013
- Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literatureJournal of Neuro-Oncology, 2013
- Emotional functioning of patients with neurofibromatosis tumor suppressor syndromeGenetics in Medicine, 2012
- The Pathoetiology of Neurofibromatosis 1The American Journal of Pathology, 2011
- Quality of life in rare genetic conditions: A systematic review of the literatureAmerican Journal of Medical Genetics Part A, 2010
- Mind-body medicine: An introduction and review of the literatureMedical Clinics of North America, 2002
- Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 PatientsScience, 1990
- Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locusCell, 1990